From C-Reactive Protein to Interleukin-6 to Interleukin-1: Moving Upstream To Identify Novel Targets for Atheroprotection
about
The Role of Dietary Inflammatory Index in Cardiovascular Disease, Metabolic Syndrome and MortalityHypercholesterolemia Tunes Hematopoietic Stem/Progenitor Cells for Inflammation and Atherosclerosis"Inflammaging" as a Druggable Target: A Senescence-Associated Secretory Phenotype-Centered View of Type 2 DiabetesRole of circulating factors in cardiac aging.Association between dietary inflammatory index and inflammatory markers in the HELENA study.Associations among apolipoproteins, oxidized high-density lipoprotein and cardiovascular events in patients on hemodialysisThe addition of vildagliptin to metformin prevents the elevation of interleukin 1ß in patients with type 2 diabetes and coronary artery disease: a prospective, randomized, open-label study.Hematopoietic stem cells gone rogue.Cytokines: roles in atherosclerosis disease progression and potential therapeutic targetsNutraceutical therapies for atherosclerosis.Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol.Hypoxic-Preconditioned Bone Marrow Stem Cell Medium Significantly Improves Outcome After Retinal Ischemia in Rats.Adiposity during adolescence and carotid intima-media thickness in adulthood: Results from the 1993 Pelotas Birth Cohort.The Angiotensin-(1-7)/Mas Axis Counteracts Angiotensin II-Dependent and -Independent Pro-inflammatory Signaling in Human Vascular Smooth Muscle CellsResolution of Acute Inflammation and the Role of Resolvins in Immunity, Thrombosis, and Vascular Biology.C-reactive protein binds to integrin α2 and Fcγ receptor I, leading to breast cell adhesion and breast cancer progression.Low-moderate urine arsenic and biomarkers of thrombosis and inflammation in the Strong Heart Study.Where Does Inflammation Fit?Safety profile of biological therapies for treating rheumatoid arthritis.The Genetic Architecture of Coronary Artery Disease: Current Knowledge and Future Opportunities.C1q/TNF-related protein 9 inhibits the cholesterol-induced Vascular smooth muscle cell phenotype switch and cell dysfunction by activating AMP-dependent kinase.Salivary microbiome of an urban Indian cohort and patterns linked to subclinical inflammation.Delta-Like Ligand 4-Notch Signaling in Macrophage Activation.Cardiovascular pharmacogenetics: a promise for genomically-guided therapy and personalized medicine.Vascular inflammation and low-density lipoproteins: is cholesterol the link? A lesson from the clinical trials.Interleukin-1 Blockade for the Treatment of Pericarditis.HIV-1-Associated Atherosclerosis: Unraveling the Missing Link.Natural Biflavonoids Modulate Macrophage-Oxidized LDL Interaction In Vitro and Promote Atheroprotection In Vivo.Differentiation of obese patients at moderate or higher Findrisc score based on their atherogenic index.Supplemental N-acetylcysteine and other measures that boost intracellular glutathione can downregulate interleukin-1β signalling: a potential strategy for preventing cardiovascular events?High-sensitivity C reactive protein as a predictor of inhospital mortality in patients with cardiovascular disease at an emergency department: a retrospective cohort studyDifferential Relationships among Circulating Inflammatory and Immune Activation Biomediators and Impact of Aging and Human Immunodeficiency Virus Infection in a Cohort of Injection Drug Users.Elevated plasma levels of interleukin-16 in patients with acute myocardial infarction.Mothers' childhood hardship forecasts adverse pregnancy outcomes: Role of inflammatory, lifestyle, and psychosocial pathways.Peripheral inflammation related to lower fMRI activation during a working memory task and resting functional connectivity among older adults: a preliminary study.Comprehensive metabolic profiling of chronic low-grade inflammation among generally healthy individuals.Posttransplant Immune Activation: Innocent Bystander or Insidious Culprit of Posttransplant Accelerated Atherosclerosis.Modulating Neuroinflammation to Treat Neuropsychiatric Disorders.A randomized study of dietary composition during weight-loss maintenance: Rationale, study design, intervention, and assessment.CRP Genotypes Predict Increased Risk to Co-Present with Low Vitamin D and Elevated CRP in a Group of Healthy Black South African Women.
P2860
Q26741434-FAECB8BC-C307-4D60-9497-59D9C4250E3CQ26742064-80E5D423-1EC6-423B-B0B9-10CB9ABB1B8FQ26747251-4557B7FB-2B0D-4141-94FB-B254B6E7C6EBQ30234641-95112438-8D6A-4F95-9EA9-A7B2DE43F8BEQ30240045-4516B598-9486-4255-AB9B-7B0F40DB7577Q33704372-3DEE6C20-47BB-4256-A78B-492E52111D76Q33716972-D1773D31-DA61-49E0-9B53-CF8AC5DA2260Q34551995-0922213C-C1F7-423E-BFAD-DEEEB6BE219DQ36064353-4D325ED8-8F8D-4097-B149-EEBEB07339D5Q36068816-83FE96EB-6C30-4AD1-8D00-91CF79135C63Q37057113-4B312BB3-D278-454A-97AC-F12349BC85F3Q37126430-ED653C78-6106-4765-80CF-4B08653E8410Q37494986-FFC27803-15F3-431C-B319-D2C0214FF7C2Q37503859-EA2FCD78-BBF2-4F7D-8EF8-346CCEE18B46Q37603197-EDC53E0C-E80E-4392-8E22-3108367920BDQ38399277-797012AC-C060-4379-AED2-1A1806FE2B3FQ38400520-DE319714-277B-4CFE-913A-ED3F453CF301Q38639570-6171A303-848F-42DB-94A1-9BEF5423CBEFQ38665700-4F6187C9-3397-481C-A0DF-73536A1218F9Q38764871-CF8BBCF9-4D85-4476-9781-3BEDEC2892DFQ38775075-F9535B86-B61F-414F-BE4B-5C72AFFF2F4AQ38850302-A3FBE846-5443-468F-9E4E-D72B57BADF5EQ38937592-161750F8-36DC-406B-BE6A-A884C05BAF31Q38974781-CE357043-A5DC-4B7C-9E14-5D3086B9609CQ39215606-88B2BC80-9B01-4213-ACBA-BC4A5B94411DQ39386445-39CF7043-F20D-4504-8D21-AA13256923ADQ39392100-A5E635D9-ED25-4F4C-B3DA-FCF8726CC268Q39504039-D7D2DA57-6F3D-46BC-B381-BE36C8A1560FQ40517664-455125E8-76B7-4E10-96E8-FFEC334C74F7Q42351011-85DA260D-5CA3-40E0-ACB4-EFC99B204AD7Q42376782-C07395AB-EB59-4B17-990D-C0C4EE71CF0FQ43135958-D73CCC12-39AE-4988-A0D9-40BDA64838E2Q45789037-93165844-0F3E-4F3A-A673-5E472340CBB6Q46264552-B8E38276-027C-4910-953F-130069F473B8Q46266623-8E1BC2D5-6292-4B7B-B300-481B86F2F51CQ47095098-D5315B4F-A04E-4A5A-8DCF-969F4D19FC17Q47119851-E36B74C1-B2AE-4034-A678-98777379FCC5Q47140966-DD33A85A-00E8-44F3-9AC2-EB1A3B7C9AE1Q47174082-B0B9C4CC-4EB2-4BEE-A9BB-6C34434130EFQ47213879-188465AF-A00C-47FF-9BE5-35FC09ECE51E
P2860
From C-Reactive Protein to Interleukin-6 to Interleukin-1: Moving Upstream To Identify Novel Targets for Atheroprotection
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
From C-Reactive Protein to Int ...... l Targets for Atheroprotection
@ast
From C-Reactive Protein to Int ...... l Targets for Atheroprotection
@en
From C-Reactive Protein to Int ...... l Targets for Atheroprotection
@nl
type
label
From C-Reactive Protein to Int ...... l Targets for Atheroprotection
@ast
From C-Reactive Protein to Int ...... l Targets for Atheroprotection
@en
From C-Reactive Protein to Int ...... l Targets for Atheroprotection
@nl
prefLabel
From C-Reactive Protein to Int ...... l Targets for Atheroprotection
@ast
From C-Reactive Protein to Int ...... l Targets for Atheroprotection
@en
From C-Reactive Protein to Int ...... l Targets for Atheroprotection
@nl
P2860
P3181
P1433
P1476
From C-Reactive Protein to Int ...... l Targets for Atheroprotection
@en
P2093
Paul M Ridker
P2860
P304
P3181
P356
10.1161/CIRCRESAHA.115.306656
P407
P577
2016-01-08T00:00:00Z